One reliable indicator of investor behavior suggests that stock valuations in developed markets will peak in the next decade or so and then begin a long-term decline. The measurement for this ...

The technical pattern of multiyear bases and subsequent absolute and relative breakouts is highly reminiscent of the pattern experienced by gold at the start of the century, which took the yellow ...

Known for his colorful stream-of-consciousness notes examining derivatives, McElligott taps the ever-expanding lexicon of Trump trades to tout the 'Trump Collar' as a way to explain the latest market ...

BioNTech and Bristol Myers Squibb have agreed to jointly develop and commercialize BioNTech's BNT327 cancer-drug candidate in a deal potentially worth more than $11 billion to the German drugmaker.